China National Accord Medicines Corporation: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
China National Accord Medicines Corporation: Legal Opinions of the 2023 Annual General Meeting of Shareholders
China National Accord Medicines Corporation: Company 2023 ESG Report
China National Accord Medicines Corporation: Announcement of Supervisory Board Resolutions
China National Accord Medicines Corporation: Announcement of Board Resolutions
China National Accord Medicines Corporation: 2024 First Quarter Report
Sinopharm Consistency: 000028 Sinopharm Investor Relations Management Information 20240422
Sinopharm agrees: Announcement of the resolution of the first interim meeting of the 9th Supervisory Board in 2024
Sinopharm agrees: Announcement on additional provisional proposals for the 2023 Annual General Meeting of Shareholders and Supplementary Notice of the Shareholders\' Meeting
Sinopharm unites: announcement on holding the 2023 annual results briefing
Sinopharm's agreement: announcement on the resignation of a director
Sinopharm agrees: Announcement of the resolution of the 2nd Interim Meeting of the 9th Board of Directors in 2024
Sinopharm is consistent: 2023 annual financial report
Sinopharm is consistent: 2023 annual audit report
Sinopharm is consistent: internal control audit report
Sinopharm\'s agreement: announcement on the forecast of daily related transactions between the company and its subsidiaries and related parties in 2024
Sinopharm agrees: the company\'s 2023 independent director debriefing report - Chen Shengqun
Sinopharm agrees: Report on the company\'s continuous risk assessment of Sinopharm Group Finance Co., Ltd.
Sinopharm is consistent: 2023 annual report summary
Sinopharm agrees: Report on the work of the company\'s 2023 board of supervisors
No Data